Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Noninterventional, Multicentre, Prospective, Cohort Study Assessing the Quality of Life and Hormonal Levels in Premenopausal Patients With Hormone Receptor-positive and HER2-negative Early Breast Cancer in Italy - ROSE Study

NCT05377684 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT05377684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05377684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Noninterventional, Multicentre, Prospective, Cohort Study Assessing the Quality of Life and Hormonal Levels in Premenopausal Patients With Hormone Receptor-positive and HER2-negative Early Breast Cancer in Italy - ROSE Study
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
June 9, 2022
Completion date
June 4, 2026
Enrollment
450 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

early-stage breast cancer